Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Brain Dopaminergic Signaling in Opioid Use Disorders (OUD)

NCT03190954 is registered in ClinicalTrials.gov with National Institute on Alcohol Abuse and Alcoholism (NIAAA) as lead sponsor.

NCT NCT03190954
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03190954 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Brain Dopaminergic Signaling in Opioid Use Disorders (OUD)
Lead sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Phase
Phase 1
Overall status
Completed
Start date
August 17, 2017
Completion date
October 27, 2025
Enrollment
153 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

normal physiology, opioid use disorders